CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

BACKGROUND: Clinical laboratory reference intervals have not been established in many African countries, and non-local intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African participants. Using laboratory reference intervals derived from other populat...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Karita, E, Ketter, N, Price, M, Kayitenkore, K, Kaleebu, P, Nanvubya, A, Anzala, O, Jaoko, W, Mutua, G, Ruzagira, E, Mulenga, J, Sanders, E, Mwangome, M, Allen, S, Bwanika, A, Bahemuka, U, Awuondo, K, Omosa, G, Farah, B, Amornkul, P, Birungi, J, Yates, S, Stoll-Johnson, L, Gilmour, J, Stevens, G, Shutes, E, Manigart, O, Hughes, P, Dally, L, Scott, J, Stevens, W, Fast, P, Kamali, A
Format:	Journal article
Sprache:	English
Veröffentlicht:	Public Library of Science 2009

Ähnliche Einträge

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.
von: Etienne Karita, et al.
Veröffentlicht: (2009-01-01)

Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.
von: Price, M, et al.
Veröffentlicht: (2011)

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.
von: Stevens, W, et al.
Veröffentlicht: (2008)

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.
von: Wendy Stevens, et al.
Veröffentlicht: (2008-04-01)

A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category
von: Ming M. Zhang, et al.
Veröffentlicht: (2023-09-01)

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.
von: Wallis, C, et al.
Veröffentlicht: (2010)

Time to switch from CLSI to EUCAST? a Southeast Asian perspective
von: Cusack, T, et al.
Veröffentlicht: (2019)

HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study.
von: Eugene Ruzagira, et al.
Veröffentlicht: (2011-01-01)

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.
von: Price, M, et al.
Veröffentlicht: (2012)

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa
von: Ngongo BP, et al.
Veröffentlicht: (2012-09-01)

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya
von: Mutua G, et al.
Veröffentlicht: (2012-09-01)

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
von: Cusack, T-P, et al.
Veröffentlicht: (2019)

Eﬀect of Diﬀerences in the CLSI and EUCAST Criteria on the Interpretation of Enterobacteriaceae Sensitivity to Carbapenems
von: L. A. Kornoukhova, et al.
Veröffentlicht: (2021-10-01)

Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing.
von: Anzala, O, et al.
Veröffentlicht: (2008)

Estudo comparativo entre as metodologias preconizadas pelo CLSI e pelo EUCAST para avaliação da atividade antifúngica Comparative study of the recommended methodologies by CLSI and EUCAST for activity evaluation antifungal
von: Marcos Aurélio Stoppa, et al.
Veröffentlicht: (2009-01-01)

Change of antibiotic susceptibility testing guidelines from CLSI to EUCAST: influence on cumulative hospital antibiograms.
von: Aline Wolfensberger, et al.
Veröffentlicht: (2013-01-01)

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions.
von: Li, X, et al.
Veröffentlicht: (2014)

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions
von: Li, X, et al.
Veröffentlicht: (2014)

Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda.
von: Eugene Ruzagira, et al.
Veröffentlicht: (2011-01-01)

Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya.
von: Nyiro, J, et al.
Veröffentlicht: (2011)

Evaluations of Antifungal Susceptibilities Have to Be According to Reference Guidelines: CLSI and EUCAST
von: Ali Korhan Sığ
Veröffentlicht: (2022-01-01)

Comparison of clinical antibiotic susceptibility testing interpretations to CLSI standard interpretations
von: Erin Hitchingham, et al.
Veröffentlicht: (2023-06-01)

CLSI Guided Reference Interval Limits for Cancer Biomarkers for Adults and Geriatrics
von: Richard M. Gitimu, et al.
Veröffentlicht: (2022-06-01)

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.
von: Jaoko, W, et al.
Veröffentlicht: (2008)

Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.
von: Tang, J, et al.
Veröffentlicht: (2011)

P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
von: Asiki G, et al.
Veröffentlicht: (2009-10-01)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.
von: Amornkul, P, et al.
Veröffentlicht: (2013)

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates
von: Jochem B. Buil, et al.
Veröffentlicht: (2018-08-01)

HLA-B*57 versus HLA-B*81 in HIV-1 infection: Slow and steady wins the race?
von: Prentice, H, et al.
Veröffentlicht: (2013)

Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.
von: Prentice, H, et al.
Veröffentlicht: (2013)

Pooled Antibiotic Susceptibility Testing for Polymicrobial UTI Performs Within CLSI Validation Standards
von: Richard A. Festa, et al.
Veröffentlicht: (2025-02-01)

Novedades CLSI y EUCAST 2024 sobre detección y uso de antibióticos
von: Diego Herrera, et al.
Veröffentlicht: (2024-08-01)

Challenges, Issues and Warnings from CLSI and EUCAST Working Group on Polymyxin Susceptibility Testing
von: Yamuna Devi Bakthavatchalam, et al.
Veröffentlicht: (2017-08-01)

International health research monitoring: exploring a scientific and a cooperative approach using participatory action research.
von: Chantler, T, et al.
Veröffentlicht: (2014)

International health research monitoring: Exploring a scientific and a cooperative approach using participatory action research
von: Chantler, T, et al.
Veröffentlicht: (2014)

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.
von: Peters, B, et al.
Veröffentlicht: (2007)

Control of the HIV-1 load varies by viral subtype in a large cohort of African adults with incident HIV-1 infection
von: Price, M, et al.
Veröffentlicht: (2019)

Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
von: Karita, E, et al.
Veröffentlicht: (2007)

Влияние расхождений критериев CLSI и EUCAST на интерпретацию чувствительности Enterobacteriaceae к карбапенемам
Veröffentlicht: (2021-10-01)

Training trial staff in the use of a mixed method assessment of understanding tool in HIV vaccine trials
von: Mbogua J, et al.
Veröffentlicht: (2012-09-01)